Eliminate the Confusion - New Requirements for Clinical Laboratories to Meet GCP

This webinar will help clinical laboratories, analyzing samples from clinical trials, understand the compliance requirements concerning ICH GCP for FDA and EMA compliance.

Purchase using Webinar All-Access Pass
One User Unlimited access to all recorded webinars for 6 Months

Recorded Version Only

(PPT + Recorded Streaming Link)

1x Person - Unlimited viewing for 6 Months (For multiple locations contact Customer Care)
rec Recorded Link and Ref. material will be available in My Account Section
Last Recorded Date: Jul-2021
Customer Care

Fax: +1-650-362-2367

Email: customercare@fdatrainingalert.com

Follow us:

The Society of Clinical Research Associates (SOCRA - www.SOCRA.org) accepts documentation of candidate participation in continuing education programs for recertification if the program is applicable to clinical research regulations, operations or management, or to the candidate’s clinical research therapeutic area. This program offers 1 hours of CE credit.

Areas Covered in the Webinar:
  • What does GCP and the new guidance require of clinical laboratories?
  • What parts of GCP apply to clinical laboratories?
  • What standards should the laboratory be working to?
  • How to assess a clinical laboratory? Sponsor companies should assess the laboratory before placement to ensure that all aspects of GCP are satisfactorily addressed and that the laboratory standards and methods meet GCP requirements.
  • Facilities to assess the orderliness, cleanliness and environmental suitability of premises where study specific activities are to be carried out and the arrangements for storage of materials and samples.
  • Procedures for sample collection, receipt and application of acceptance/rejection criteria and for the preparation of reagents.
  • What documentation should be available – including SOPs, validation, technical agreements.
  • What is required to ensure quality and appropriateness of methodology in use in any laboratory?
  • What should be included in the contract between the laboratory and the sponsor?
  • What is the role of the sponsor company and laboratory during the study for ensuring clinical trials sample management and analysis to meet GCP requirements?
Who Will Benefit:

This webinar will provide critical assistance to FDA and EMA regulated companies currently carrying out or preparing to conduct clinical trials for pharmaceutical, biotechnology, and biologics products using clinical laboratories. It will also be applicable to personnel working in clinical laboratories.

  • Clinical development managers and personnel
  • Clinical research associates
  • Clinical research archiving and document management personnel
  • Quality assurance managers and auditors
  • Clinical development managers and personnel
  • CROs using laboratories to analyze clinical trial samples
  • Sponsors and non-commercial sponsors
  • Sponsors who have their own laboratories for analyzing clinical trial samples
  • Consultants
  • Laboratories analyzing samples from clinical trials
  • Professionals responsible for contracts
Instructor Profile:
Laura Brown Laura Brown

Independent QA and Training Consultant, Laura Brown Training and Development

Dr Laura Brown is an independent Pharmaceutical QA, Management and Training Consultant, and Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. Laura has more than 20 years' experience of Quality Assurance and managing international clinical trials including risk identification and management and risk based monitoring. She has worked for several companies including GSK, Hoechst Marion Roussel, Good Clinical Research Practices and Phoenix International. She has consulted with numerous pharmaceutical companies, suppliers to the pharmaceutical industry as well as academic institutions.

Dr Brown has an MBA with specialization in project management including risk management. She is also the external project management expert for a pharmaceutical e-learning MSc module in project management covering risk management, and the author of two books on project management including the leading book “Pharmaceutical Project Management” (Gower).

Topic Background:

Article 15 of EU Clinical Trials Directive 2001/20/EC provides provision for the inspection of laboratories that perform the analysis or evaluation of samples collected as part of a clinical trial and so companies must ensure the laboratories they use are in compliance with good clinical practice. Many laboratories are currently not meeting these requirements. It is essential to ensure compliance you are aware of that sponsors and laboratories should have in place to meet these new standards which regulatory inspectors are now inspecting against.

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

You Recently Viewed